SOURCE: StockCall

StockCall

May 03, 2011 08:56 ET

Analyst Research on Hologic Inc. and Zimmer Holdings Inc. -- Rebounding Demand in Medical Appliances and Equipment Sector

JOHANNESBURG, SOUTH AFRICA--(Marketwire - May 3, 2011) - www.stockcall.com/ offers investors comprehensive research on the Medical Appliances & Equipment industry and has completed analytical research on Hologic Inc. (NASDAQ: HOLX) and Zimmer Holdings Inc. (NYSE: ZMH). Register with us today at www.stockcall.com/ to have free access to these researches.

The economic downturn proved to be a tough time for some companies in the Medical Appliances and Equipment Sector. The volume of elective procedures went down considerably as large portions of the United States became worried about missing work in a down economy or losing their jobs and insurance altogether. However, now that the economy has begun to improve again and patients are gaining more confidence, it is hoped that procedures will return to their previous levels. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Medical Appliances & Equipment industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Medical Appliances & Equipment industry can have easy and free access to our analyst research and opinions on Hologic Inc. and Zimmer Holdings Inc.; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

Knee replacement markets have been especially challenged because they are typically used by the younger demographic. There has been slightly increased demand for joint replacements lately. Hip replacements preformed the best of any joint while most others remained sluggish. Some of the deferred treatments should also start showing up now that the patients can either afford or no longer put off the procedures. This could bode well for Zimmer Holdings Inc. which saw its Q1 earnings grow 1.7% on the strength of some newly launched products. Investors looking for complimentary research on Zimmer Holdings Inc. are welcome to sign up at www.stockcall.com/ZMH030511.pdf for our new report.

Elsewhere in the sector, companies in the HPV test market like Hologic Inc. will be getting a little more competition now that the FDA has approved a new product by Roche Holding AG. This market could potentially grow as many countries, especially in Europe, have yet to adopt automated testing. There should be a great opportunity for companies in this segment moving forward so long as the competition does not become too fierce. Investors looking for free research on Hologic Inc. are welcome to sign up at www.stockcall.com/HOLX030511.pdf for our new report.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information